David Fallace
InvestorManaging Partner at Cure Ventures
Massachusetts
Writes $100K β $5M checks Β· typically $1.5M
About
Managing Partner and Co-Founder of Cure Ventures with over 20 years investing in venture and alternative asset funds. Previously advised Polaris Partners and held roles at TIFF Investment Management, the Alaska Permanent Fund and GF Private Equity Group.
Experience
- Cure VenturesManaging Partner and Co-foundercurrent2021 β presentBoston, Massachusetts, United States
- Polaris PartnersAdviser2018 β 2019Boston, Massachusetts
- The Investment Fund for FoundationsManaging Director2016 β 2017Greater Boston
- Codiak BiosciencesInvestor2015 β 2016Greater Boston
- Denali TherapeuticsBoard Observer2015 β 2016San Francisco Bay Area
- Alaska Permanent Fund CorporationDirector - Special Opportunities2013 β 2016Juneau, Alaska
- Juno TherapeuticsBoard Observer2013 β 2014Greater Seattle Area
- Haugen Financial SystemsVice President2009 β 2013
- GF Private Equity GroupVice President2000 β 2009
Education
- University at Buffalo School of Management, The State University of New YorkMBA, Finance1994 β 1999
- University at Buffalo School of LawJuris Doctor, Tax and Financial Transactions1994 β 1998
Skills & more
Private Equity50Portfolio Management35Hedge Funds25Real Estate10Alternative Investments27Venture Capital43Asset Management16Asset Allocation1Corporate Development1Derivatives1Asset Managment3Emerging Markets1
From David's professional profile.
Same school
Also attended University at Buffalo School of Management, The State University of New York12
Joshua GilbertInvestor at TMV LogisticsFouad AzzamPartner at EQT Life SciencesDaniel PenberthyPresident and Chief Executive Officer at Rand CapitalKunal SinhaVenture Partner at Zero Infinity PartnersBill DrmacichManaging Director at SG Credit PartnersRaymond DenneyPartner/COO/CCO at Wakem Capital Management
+ 6 more
Also attended University at Buffalo School of Law2
Shared employers
Also worked at Polaris Partners32
Dylan PearcePartner at GreycroftGraham BrownManaging Partner at Lerer HippeauMichael GreeleyCo-Founder and General Partner at Flare Capital PartnersSimeon SimeonovAdvisor at One Way VenturesDave BarrettSenior Advisory Partner at Polaris PartnersAlexandra CantleyManaging Partner at Polaris Partners
+ 26 more
Also worked at The Investment Fund for Foundations3
Also worked at Denali Therapeutics2
Also worked at Juno Therapeutics2
Deals Β· 2
Tasca Therapeutics CorpBoard seat
via Cure Ventures Β· filed Dec 2025 Β· $70.2M raise
RYNE Biotechnology Inc.Board seat
via Cure Ventures Β· filed Mar 2024 Β· $81.8M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
James Vath
Partner at Cure Ventures
Network5
Bill Amsbaugh
CTO and Partner at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
James Vath
Partner at Cure Ventures
Kenzie Maclsaac
Partner at Cure Ventures
May Han
Partner at Cure Ventures
Investors connected to David in public investor directories β a warm-intro map.




























